Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer

James Krempski, Lavakumar Karyampudi, Marshall D. Behrens, +6

The Journal of Immunology

Dendritic CellImmunologyImmune RegulationCell DeathImmunoediting +14

Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma

Aaron S. Mansfield, Tobias Peikert, James B. Smadbeck, +23

Journal of Thoracic Oncology

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

Håkan Norell, Isabel Poschke, Jehad Charo, +7

Journal of Translational Medicine

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

Kimberly R. Kalli, Matthew S. Block, Pashtoon Murtaza Kasi, +11

Clinical Cancer Research

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

Marshall D. Behrens, Wolfgang Wagner, Christopher J. Krco, +6

Blood

Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

Matthew S. Block, Allan B. Dietz, Michael P. Gustafson, +20

Nature Communications

T-Cell Immunity to the Folate Receptor Alpha Is Prevalent in Women With Breast or Ovarian Cancer

Keith L. Knutson, Christopher J. Krco, Courtney L. Erskine, +6

Journal of Clinical Oncology

Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain

Keith L. Knutson, Raphael Clynes, Barath Shreeder, +12

Cancer Research

Breast OncologyImmunologyImmunotherapyTumor ImmunologyTetanus Toxoid +14

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

Dmitriy Zamarin, Sven Walderich, Aliya Holland, +16

Journal for ImmunoTherapy of Cancer

ImmunologyImmune RegulationGynecologyImmunotherapeuticsImmune Cell Therapy +21

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Courtney L. Erskine, Andrea M. Henle, Keith L. Knutson

Journal of Visualized Experiments

Xcelligence SystemCell TherapyImmunotoxicologyImmunologyImmunophenotyping +15